Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni

Nobuko Kojima; Hayato Tada; Hirofumi Okada; Shohei Yoshida; Kenji Sakata; Soichiro Usui; Hiroko Ikeda; Masaki Okajima; Masa-aki Kawashiri; Masayuki Takamura

doi:10.3389/fcvm.2022.837759

Frontiers in Cardiovascular Medicine (Mar 2022)

Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni

Nobuko Kojima,
Hayato Tada,
Hirofumi Okada,
Shohei Yoshida,
Kenji Sakata,
Soichiro Usui,
Hiroko Ikeda,
Masaki Okajima,
Masa-aki Kawashiri,
Masayuki Takamura

Affiliations

Nobuko Kojima: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Hayato Tada: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Hirofumi Okada: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Shohei Yoshida: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Kenji Sakata: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Soichiro Usui: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Hiroko Ikeda: Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan
Masaki Okajima: Department of Emergency Medicine, Kanazawa University Hospital, Kanazawa, Japan
Masa-aki Kawashiri: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
Masayuki Takamura: Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan

DOI: https://doi.org/10.3389/fcvm.2022.837759
Journal volume & issue: Vol. 9

Abstract

Read online

We herein present our experience with a case involving a 17-year-old Japanese boy suffering from acute myocarditis after his second coronavirus disease-2019 (COVID-19) messenger RNA (mRNA) vaccine shot. The patients had a history of myocarditis associated with Campylobacter jejuni 3 years prior. This has been the first-ever documented case of myocarditis associated with COVID-19 mRNA vaccination in a patient with a history of myocarditis. We present a series of images and blood biomarkers for different types of myocarditis that developed in this single patient.

Published in Frontiers in Cardiovascular Medicine

ISSN: 2297-055X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.frontiersin.org/journals/cardiovascular-medicine

About the journal

Abstract

Keywords